17.09.2024 – 14:05ARTTIC Innovation GmbHLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"Challenge CallEin Dokumentmehr
17.09.2024 – 14:00ARTTIC Innovation GmbHLaunch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"Challenge CallEin Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
29.08.2024 – 14:03ARTTIC Innovation GmbHcanSERV relaunches Open Call for Service ProvisionOpen CallEin Dokumentmehr
02.07.2024 – 14:00ARTTIC Innovation GmbHcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision OpencanSERV Challenge Calls2 Dokumentemehr
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallEin Dokumentmehr
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallEin Dokumentmehr
14.05.2024 – 09:01ARTTIC Innovation GmbHLAST CHANCE: canSERV Second Open Call for Cancer Research Service ProvisioncanSERV Open Call Ein Dokumentmehr
23.04.2024 – 14:02ARTTIC Innovation GmbH3canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer ResearchcanSERV Challenge CallEin Dokumentmehr
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigEin Dokumentmehr
01.02.2024 – 10:02Sysmex Europe SEStrengthening the Direct Sales and Service System for Business Expansion in ItalyVisit our website!Ein Dokumentmehr
18.01.2024 – 10:00ARTTIC Innovation GmbH2OPTIMA cancer project announces the Region Uppsala as new partnerCheck out the OPTIMA Videomehr
31.10.2023 – 10:00ARTTIC Innovation GmbH2PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHubPIONEER Videomehr
12.10.2023 – 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallEin Dokumentmehr
12.10.2023 – 14:00ARTTIC Innovation GmbHcanSERV Releases Open Call for Transnational Service ProvisioncanSERV CallEin Dokumentmehr
08.08.2023 – 08:00ARTTIC Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore about PIONEERmehr
10.07.2023 – 17:08Helmholtz Zentrum MünchenWildDISCO: Visualizing Whole Bodies in Unprecedented Detailmehr
05.07.2023 – 17:15Helmholtz Zentrum MünchenPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmehr
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemehr
28.06.2023 – 17:13Helmholtz Zentrum MünchenNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmehr
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmehr
24.04.2023 – 10:01Sysmex Europe SE3Sysmex Europe distributes MammaTyper®, an advanced breast cancer diagnostic assay, through the European distribution agreement with Cerca BiotechFind out more on MammaTyper here!mehr
09.03.2023 – 10:00Medias Klinikum GmbH & Co KGThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remissionmehr
01.03.2023 – 13:14ARTTIC Innovation GmbH2Free Access to Cancer Research Services - canSERV 1st Call for ProposalscanSERV websitemehr
28.02.2023 – 19:00ARTTIC Innovation GmbHFree Access to Cancer Research Services - canSERV 1st Call for ProposalsAPPLY NOW!Ein Dokumentmehr
20.10.2022 – 12:00Klinik für Prostata-Therapie HeidelbergFocal therapy for prostate cancer: Reliable diagnosis leads to gentle treatmentmehr
10.10.2022 – 17:15Helmholtz Zentrum MünchenLandscape of molecular contacts: How the coronavirus SARS-CoV-2 communicates with human cellsmehr
02.12.2021 – 00:01PM-International AGCHRISTMAS COMES EARLY FOR CHILDREN WITH CANCER COURTESY OF PM-INTERNATIONAL MALAYSIAmehr
20.10.2021 – 16:30Sysmex Inostics GmbHNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inosticsmehr
01.07.2021 – 06:01Fördergesellschaft IZB mbH7Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021In the IZB you can find over 50 biotech start-upsEin Dokumentmehr